Respiratory News and Research

RSS

Researchers identify two promising candidates for development of drugs to combat adenovirus

Scientists at the U.S. Department of Energy's Brookhaven National Laboratory have identified two promising candidates for the development of drugs against human adenovirus, a cause of ailments ranging from colds to gastrointestinal disorders to pink eye.

3 Jul 2013

Bioline announces worldwide release of MyTaq Extract-PCR Kit

Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc., is proud to announce the worldwide release of the MyTaq Extract-PCR Kit.

2 Jul 2013

Alnylam Pharmaceuticals presents new pre-clinical data of ALN-AT3 at ISTH meeting

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data from its RNAi therapeutic program for the treatment of hemophilia and rare bleeding disorders.

2 Jul 2013

Study describes radiologic findings in H7N9 pneumonia

H7N9 pneumonia is characterized by imaging findings that differentiate it from other types of pneumonia, including rapidly progressive changes in the lungs and pulmonary connective tissues, according to the first study to describe radiologic findings in the disease. The results are published online in the journal Radiology.

2 Jul 2013

ATS releases statement on ethical, health policy considerations surrounding DCDD process

The American Thoracic Society has released an official statement on the ethical and health policy considerations surrounding adult and pediatric controlled organ donation after circulatory determination of death, the recovery of organs after cessation of circulation from patients with severe neurological, neuromuscular or pulmonary disease for whom decisions are made to forego additional life-prolonging treatments.

1 Jul 2013

Coughs give vital clues to confirm the presence of pneumonia in children

A new method, which analyzes the sounds in a child's cough, could soon be used in poor, remote regions to diagnose childhood pneumonia reliably. According to Udantha Abeyratne from the University of Queensland in Australia and colleagues, this simple technique of recording coughs with a microphone on the patient's bedside table, has the potential to revolutionize the management of childhood pneumonia in remote regions around the world.

28 Jun 2013

EMA's CHMP issues positive opinion for approval of Genzyme's LEMTRADA in Europe

Genzyme, a Sanofi company, announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion for approval of LEMTRADA (alemtuzumab) for the treatment of adult patients with relapsing remitting multiple sclerosis with active disease defined by clinical or imaging features.

28 Jun 2013

Acute Palliative Care Unit: A new frontier in managing patients with end-stage chronic disease

A new study shows that hospitals with specialized units combining the compassionate care of hospice and the level of care offered in medical-surgical units may provide efficient, cost effective assistance to patients with advanced chronic illness or terminal disease.

28 Jun 2013

FDA approves Novartis' Exelon Patch for treatment of severe Alzheimer's disease

The US Food and Drug Administration has expanded the approved indication for Exelon Patch (rivastigmine transdermal system) to include the treatment of people with severe Alzheimer's disease with Exelon Patch 13.3mg/24h.

28 Jun 2013

Physician offers helpful tips to a healthy summer

Summer is officially here, and for many, so is the threat of sunburn, bug bites and allergies. Deepti Shivakumar, MD, family practice at Gottlieb Memorial Hospital, offers some helpful tips to a healthy summer.

27 Jun 2013

Research shows influenza infection increases susceptibility to pneumococcus bacteria by 100-fold

It's been known for more than two centuries that pneumonia cases increase during flu epidemics. But population-level epidemiological studies looking at seasonal patterns of influenza and pneumococcal pneumonia incidence have revealed either a modest association or have failed to identify any signature of interaction between the two.

27 Jun 2013

A paradigm shift for treatment of muscular dystrophy

Researchers at Boston University College of Health & Rehabilitation Sciences: Sargent College have identified a combinatorial therapeutic approach that has proven effective in treating muscular dystrophy in a mouse model.

26 Jun 2013

BioFire Diagnostics' FilmArray Blood Culture Identification Panel receives FDA clearance

BioFire Diagnostics, Inc., announced today the FDA clearance of its FilmArray Blood Culture Identification Panel. To date, the 27-target panel is the most comprehensive test to be approved by the FDA.

26 Jun 2013

Study shows risk of Guillain-Barre syndrome after vaccination is extremely low

Patients are not at increased risk of Guillain-Barr- syndrome in the six-week period after vaccination with any vaccine, including influenza, according to a Kaiser Permanente study published in Clinical Infectious Diseases.

25 Jun 2013

Patients with type2 diabetes, renal impairment have less hypoglycemia with JANUVIA compared to sulfonylurea

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from a post-hoc pooled analysis showing patients with type 2 diabetes and mild renal impairment treated with JANUVIA- (sitagliptin) 100 mg once-daily achieved similar blood sugar reductions as those treated with the sulfonylureas glipizide or glimepiride, with significantly fewer events of hypoglycemia (low blood sugar), and with weight loss instead of weight gain.

24 Jun 2013

Study: Risk factors in indoor environment of modern apartments related to pneumonia among children

Childhood pneumonia is the leading causes of death among children in China and worldwide. Using coal or wood as cooking fuel in rural area was considered as major cause of Pneumonia. However, the incidence of childhood pneumonia is still high in urban modern cities.

24 Jun 2013

EC grants marketing authorization for XTANDI capsules for treating advanced prostate cancer

Astellas Pharma Europe Ltd., the European Headquarters of Tokyo-based Astellas Pharma Inc. (TSE:4503), and Medivation, Inc. announced that following the regulatory review process by the European Medicines Agency (EMA) and a positive opinion from the Committee for Medicinal Products for Human Use on April 25, 2013, the European Commission (EC) has granted the marketing authorization for XTANDI™ (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy.

24 Jun 2013

Alnylam presents new pre-clinical data of ALN-CC5 for treatment of complement-mediated diseases

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with ALN-CC5, an RNAi therapeutic targeting complement component C5.

21 Jun 2013

HIV-derived antibacterial compounds could be potential treatments for drug-resistant bacterial infections

A team of researchers at the University of Pittsburgh has developed antibacterial compounds, derived from the outer coating of HIV, that could be potential treatments for drug-resistant bacterial infections and appear to avoid generating resistance. These new agents are quite small, making them inexpensive and easy to manufacture.

20 Jun 2013

Bristol-Myers Squibb and AstraZeneca announce top line results of Phase 4 SAVOR-TIMI-53 clinical trial of Onglyza

Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced top line results of the Phase 4 SAVOR-TIMI-53 (Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus) clinical trial of Onglyza ® (saxagliptin).

20 Jun 2013

Respiratory News and Research

Researchers identify two promising candidates for development of drugs to combat adenovirus

Bioline announces worldwide release of MyTaq Extract-PCR Kit

Alnylam Pharmaceuticals presents new pre-clinical data of ALN-AT3 at ISTH meeting

Study describes radiologic findings in H7N9 pneumonia

ATS releases statement on ethical, health policy considerations surrounding DCDD process

Coughs give vital clues to confirm the presence of pneumonia in children

EMA's CHMP issues positive opinion for approval of Genzyme's LEMTRADA in Europe

Acute Palliative Care Unit: A new frontier in managing patients with end-stage chronic disease

FDA approves Novartis' Exelon Patch for treatment of severe Alzheimer's disease

Physician offers helpful tips to a healthy summer

Research shows influenza infection increases susceptibility to pneumococcus bacteria by 100-fold

A paradigm shift for treatment of muscular dystrophy

BioFire Diagnostics' FilmArray Blood Culture Identification Panel receives FDA clearance

Study shows risk of Guillain-Barre syndrome after vaccination is extremely low

Patients with type2 diabetes, renal impairment have less hypoglycemia with JANUVIA compared to sulfonylurea

Study: Risk factors in indoor environment of modern apartments related to pneumonia among children

EC grants marketing authorization for XTANDI capsules for treating advanced prostate cancer

Alnylam presents new pre-clinical data of ALN-CC5 for treatment of complement-mediated diseases

HIV-derived antibacterial compounds could be potential treatments for drug-resistant bacterial infections

Bristol-Myers Squibb and AstraZeneca announce top line results of Phase 4 SAVOR-TIMI-53 clinical trial of Onglyza

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News